Australian ASX200 earnings preview A2M

At the start of the pandemic, A2 Milk was a beneficiary as sales surged on a wave of panic buying. In response, A2 Milk upgraded its full-year earnings guidance in April 2020 by 32%. Shortly afterwards, in June 2020, the share price traded to its all-time high of $20.05c.

Since that point, a drastic reversal of fortune has occurred.

In its half year update in February, A2 Milk downgraded its full-year guidance in response to the fallout from a decline in daigou sales. A2 Milks products were purchased in NZ and Australia and then shipped into China to sell to customers there. The closure of international borders bought this channel to a halt that accounted for 60-70% of the region's revenue.

After an escalation in the political tensions between China and Australia, A2 Milk in May slashed its sales and earnings forecasts again and wrote down $90 million in nearly out-of-date stock, sending the share price to a low of $5.02c, almost 75% below its 2020 high.

Last week, the beaten-down share price rallied briefly above $7.00 on reports that A2 Milk has become a takeover target for Nestle. A takeover by the Swiss giant would reinvigorate A2 Milk's infant formula in China and leverage Nestles in-country distribution network. A2 Milk has declined to comment on the takeover speculation leaving the market to ponder the possibilities of a takeover.

In its last update in May, A2 Milk said that it expects full-year sales to be in the range of $NZ1.2 billion to $NZ1.25 billion and an EBITDA margin of 11 percent to 12 percent. The latter implies an EBITDA of just NZ$132 million to NZ$150 million. This compares to FY 2020's revenue of NZ$1.73 billion and EBITDA of NZ$549.7 million, a reduction of 73% to 76% year on year.

After falling from $20.05 to a low of $5.02 in just 12 months, some stability has returned to the A2 Milk price recently. Nonetheless, there aren't any obvious technical or fundamental reasons to buy A2 Milk other than for the reason a corrective bounce is possible after such a sharp sell-off. For those that think that last week's takeover rumour might, in time, prove correct, then consider buying A2 Milk at $6.57 with a stop loss placed below $5.75.

Source Tradingview. The figures stated areas of the 23rd of August 2021. Past performance is not a reliable indicator of future performance. This report does not contain and is not to be taken as containing any financial product advice or financial product recommendation

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. CFD and Forex Trading are leveraged products and your capital is at risk. They may not be suitable for everyone. Please ensure you fully understand the risks involved by reading our full risk warning.

City Index is a trading name of StoneX Financial Ltd. Head and Registered Office: 1st Floor, Moor House, 120 London Wall, London, EC2Y 5ET. StoneX Financial Ltd is a company registered in England and Wales, number: 05616586. Authorised and regulated by the Financial Conduct Authority. FCA Register Number: 446717.

City Index is a trademark of StoneX Financial Ltd.

The information on this website is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement.